These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34692363)

  • 1. Management of Stent Thrombosis Post-Percutaneous Coronary Intervention and Associated Rare Complications.
    Fadah K; Patel D; Mishra K; Makhija R; Siddiqui T
    Cureus; 2021 Sep; 13(9):e18370. PubMed ID: 34692363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subacute stent thrombosis in a patient with type 2 diabetes and clopidogrel resistance: A case report
.
    Zhou MC; Cao SP; Zhong HL; Zheng P
    Int J Clin Pharmacol Ther; 2020 Aug; 58(8):449-453. PubMed ID: 32352367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review.
    Al-Dehneh A; Virk H; Alkhouri Y; Hamdan A; Bikkina M
    Tex Heart Inst J; 2010; 37(3):343-6. PubMed ID: 20548819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Simultaneous subacute thrombosis in bare metal stents implanted into right coronary artery and left anterior descending artery without coexistence of resistance to antiplatelet therapy].
    Frynas K; Krecki R; Krzemińska-Pakuła M; Kasprzak JD
    Kardiol Pol; 2010 Sep; 68(9):1070-3; discussion 1074-5. PubMed ID: 20859908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.
    Dangas GD; Caixeta A; Mehran R; Parise H; Lansky AJ; Cristea E; Brodie BR; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Möeckel M; Stone GW;
    Circulation; 2011 Apr; 123(16):1745-56. PubMed ID: 21482968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation.
    Garg P; Mauri L
    Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.
    Wiviott SD; Braunwald E; McCabe CH; Horvath I; Keltai M; Herrman JP; Van de Werf F; Downey WE; Scirica BM; Murphy SA; Antman EM;
    Lancet; 2008 Apr; 371(9621):1353-63. PubMed ID: 18377975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of antiplatelet therapy after percutaneous coronary intervention with bare-metal stents and different types of drug-eluting stents.
    Singh T; Cuomo L; Cohen M; Ahmad HA; Aronow WS
    Curr Clin Pharmacol; 2013 Feb; 8(1):59-66. PubMed ID: 22946865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Rare Case of Coronary Stent Thrombosis in the Modern Era.
    Hussain KM; Jain A; Rane RP; Sweedan YG; Shahab A; Alam MDU; Hussain KMA
    Cureus; 2022 May; 14(5):e25207. PubMed ID: 35747031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative management of antiplatelet therapy in patients with drug-eluting stents.
    Dimitrova G; Tulman DB; Bergese SD
    HSR Proc Intensive Care Cardiovasc Anesth; 2012; 4(3):153-67. PubMed ID: 23439793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
    Newsome LT; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very late stent thrombosis of bare-metal coronary stent nine years after primary percutaneous coronary intervention.
    Đurić P; Obradović S; Stajić Z; Spasić M; Matunović R; Romanović R; Đenić N; Jović Z
    Vojnosanit Pregl; 2016 Aug; 73(8):774-8. PubMed ID: 29328614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
    Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents.
    Zimarino M; Renda G; De Caterina R
    Drugs; 2005; 65(6):725-32. PubMed ID: 15819586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Two-Year versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis after Drug-Eluting Stent Implantation.
    Poorhosseini HR; Hosseini SK; Davarpasand T; Lotfi Tokaldany M; Salarifar M; Kassaian SE; Alidoosti M; Nozari Y; Nematipour E; Haji Zeinali AM; Aghajani H; Amirzadegan AR
    J Tehran Heart Cent; 2012; 7(2):47-52. PubMed ID: 23074637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions.
    Mauri L; Kereiakes DJ; Normand SL; Wiviott SD; Cohen DJ; Holmes DR; Bangalore S; Cutlip DE; Pencina M; Massaro JM
    Am Heart J; 2010 Dec; 160(6):1035-41, 1041.e1. PubMed ID: 21146655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stent thrombosis in real-world patients: a comparison of drug-eluting with bare metal stents.
    de Man FH; Stella PR; Nathoe H; Kirkels H; Hamer B; Meijburg HW; Doevendans PA
    Neth Heart J; 2007; 15(11):382-6. PubMed ID: 18176640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nightmare: Simultaneous Subacute Stent Thrombosis of Different New-Generation Drug-Eluting Stents in Multiple Coronary Arteries.
    Hsu PC; Chiu CA; Su HM; Lin TH; Chu CS
    Acta Cardiol Sin; 2015 Mar; 31(2):175-8. PubMed ID: 27122868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of low-dose aspirin (81 mg) on the incidence of definite stent thrombosis in patients receiving bare-metal and drug-eluting stents.
    Lotfi A; Cui J; Wartak S; Columbo J; Mulvey S; Davis M; Schweiger M; Giugliano GR
    Clin Cardiol; 2011 Sep; 34(9):567-71. PubMed ID: 21792981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Late thrombosis of coronary bare-metal stent--case report].
    Apostolović S; Perisić Z; Tomasević M; Stankovic G; Pavlović M; Salinger-Martinović S
    Srp Arh Celok Lek; 2006; 134(3-4):155-8. PubMed ID: 16915758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.